Noorbala AA - Search Results

1

Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia.

Noorbala AA, Akhondzadeh S, Davari-Ashtiani R, Amini-Nooshabadi H. Noorbala AA, et al. J Clin Pharm Ther. 1999 Oct;24(5):369-74. doi: 10.1046/j.1365-2710.1999.00238.x. J Clin Pharm Ther. 1999. PMID: 10583700 Clinical Trial.

2

Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.

Noorbala AA, Hosseini SH, Mohammadi MR, Akhondzadeh S. Noorbala AA, et al. J Clin Pharm Ther. 1998 Apr;23(2):155-9. doi: 10.1046/j.1365-2710.1998.00156.x. J Clin Pharm Ther. 1998. PMID: 9786103 Clinical Trial.

3

Prevalence of obsessive-compulsive disorder in Iran.

Mohammadi MR, Ghanizadeh A, Rahgozar M, Noorbala AA, Davidian H, Afzali HM, Naghavi HR, Yazdi SA, Saberi SM, Mesgarpour B, Akhondzadeh S, Alaghebandrad J, Tehranidoost M. Mohammadi MR, et al. Among authors: noorbala aa. BMC Psychiatry. 2004 Feb 14;4:2. doi: 10.1186/1471-244X-4-2. BMC Psychiatry. 2004. PMID: 15018627 Free PMC article.

4

Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.

Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Noorbala AA, et al. J Ethnopharmacol. 2005 Feb 28;97(2):281-4. doi: 10.1016/j.jep.2004.11.004. Epub 2005 Jan 6. J Ethnopharmacol. 2005. PMID: 15707766 Clinical Trial.

5

Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.

Noorbala AA, Akhondzadeh S. Noorbala AA, et al. Arch Iran Med. 2006 Oct;9(4):374-80. Arch Iran Med. 2006. PMID: 17061613 Review.

6

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S. Amiri A, et al. Among authors: noorbala aa. Hum Psychopharmacol. 2008 Mar;23(2):79-86. doi: 10.1002/hup.902. Hum Psychopharmacol. 2008. PMID: 17972359 Clinical Trial.

7

A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.

Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S. Salimi S, et al. Among authors: noorbala aa. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):726-32. doi: 10.1016/j.pnpbp.2007.11.021. Epub 2007 Nov 23. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18096287 Clinical Trial.

8

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.

Ghaleiha A, Noorbala AA, Farnaghi F, Hajiazim M, Akhondzadeh S. Ghaleiha A, et al. Among authors: noorbala aa. J Clin Psychopharmacol. 2010 Dec;30(6):678-82. doi: 10.1097/jcp.0b013e3181fa8720. J Clin Psychopharmacol. 2010. PMID: 21105281 Clinical Trial.

9

Mental health study process into prevalence of mental disorders in Iran.

Noorbala AA, Akhondzadeh S. Noorbala AA, et al. Arch Iran Med. 2015 Feb;18(2):74-5. Arch Iran Med. 2015. PMID: 25644793 No abstract available.

10

Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial.

Jafarinia M, Afarideh M, Tafakhori A, Arbabi M, Ghajar A, Noorbala AA, Saravi MA, Agah E, Akhondzadeh S. Jafarinia M, et al. Among authors: noorbala aa. J Affect Disord. 2016 Nov 1;204:1-8. doi: 10.1016/j.jad.2016.05.076. Epub 2016 Jun 1. J Affect Disord. 2016. PMID: 27317968 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page